ReviewCurrent therapeutic research, clinical and experimental2024

Cost-effectiveness of Evolocumab in Cardiovascular Disease: A Systematic Review.

Nashmil Ghadimi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.